Quarterly report pursuant to Section 13 or 15(d)

Composition of Certain Financial Statement Captions (Tables)

v3.10.0.1
Composition of Certain Financial Statement Captions (Tables)
6 Months Ended
Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Composition of Certain Financial Statement Captions
(In thousands)
June 30,
2018
 
December 31,
2017
Accounts receivable, net:
 
 
 
Accounts receivable
$
154,269

 
$
166,962

Less: allowance for doubtful accounts
(1,492
)
 
(1,446
)
 
$
152,777

 
$
165,516

Inventories, net:
 
 
 
Consumable supplies
$
24,986

 
$
21,546

Finished products
16,783

 
21,012

Work in-process
3,910

 
5,873

Raw materials
5,800

 
7,467

Less: inventory reserve
(4,726
)
 
(6,565
)
 
$
46,753

 
$
49,333

Other current assets and prepaid expenses:
 
 
 
Taxes recoverable
21,319

 
18,138

Other receivables
2,031

 
8,798

Prepaid supplies
10,278

 
8,207

Prepaid insurance
3,259

 
3,532

Other
4,764

 
3,838

 
$
41,651

 
$
42,513

Intangible assets, net:
 
 
 
Customer relationships
$
447,225

 
$
448,345

Technologies
340,815

 
340,921

Trade names
50,494

 
50,553

Licenses
10,246

 
10,305

Covenants not to compete
16,367

 
16,372

Product registrations
9,694

 
10,475

Other
5,696

 
5,799

Less: accumulated amortization
(231,996
)
 
(198,935
)
 
$
648,541

 
$
683,835

Accrued expenses:
 
 
 
Contract liabilities
$
61,846

 
$
61,388

Employee benefits
46,621

 
50,377

Clinical trials
11,598

 
12,191

Taxes payable
3,604

 
4,609

Contingent consideration
2,042

 
11,750

Capital leases short-term
3,166

 
3,399

Milestone payment
4,967

 
4,868

Professional fees
1,727

 
2,355

Other
65,421

 
79,364

 
$
200,992

 
$
230,301

 
 
 
 
(In thousands)
June 30,
2018
 
December 31,
2017
Other long-term liabilities:
 
 
 
Contract liabilities
$
47,720

 
$
78,990

Line of credit
105,539

 
104,152

Contingent consideration
25,712

 
29,603

Mortgages and other debts payable
1,704

 
1,567

Capital leases long-term
6,638

 
7,786

Other
22,131

 
17,857

 
$
209,444

 
$
239,955

Changes in Goodwill
The following table summarizes the changes in Goodwill during the six months ended June 30, 2018.
 
2018
(In thousands)
Balance at January 1
 
Foreign exchange and other
 
Balance at June 30th
Pharmaceuticals
 
 
 
 
 
CURNA
$
4,827

 
$

 
$
4,827

EirGen
89,226

 
(2,201
)
 
87,025

FineTech
11,698

 

 
11,698

OPKO Chile
5,203

 
(307
)
 
4,896

OPKO Biologics
139,784

 

 
139,784

OPKO Health Europe
7,898

 
(197
)
 
7,701

OPKO Renal
2,069

 

 
2,069

Transition Therapeutics
3,608

 
(160
)
 
3,448

 
 
 
 
 
 
Diagnostics
 
 
 
 
 
BioReference
401,821

 

 
401,821

OPKO Diagnostics
17,977

 

 
17,977

OPKO Lab
32,988

 

 
32,988

 
$
717,099

 
$
(2,865
)
 
$
714,234